The 2023 vaccination schedule is discussed and the proposal to introduce the hexavalent, varicella and hepatitis A vaccines in children under 5 years of age is approved. The implementation of the Bivalent vaccine against COVID-19 as a booster in populations from 18 years of age is approved.

Revision of the update of Technical Guidelines on Vaccine Preventable Diseases, including the latest vaccines to be introduced in the vaccination schedule.